Does baseline cerebral blood flow affect task-related blood oxygenation level dependent response in schizophrenia?

Schizophrenia Research

Volumn 140, Issue 1-3, 2012, Pages 143-148

  Liu, Jiacheng ^a   Qiu, Maolin ^a   Constable, R Todd ^a   Wexler, Bruce E ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Arterial spin labeling; Emotion; Face processing; FMRI; Resting cerebral blood flow; Schizophrenia

Indexed keywords

ARTICLE; BASAL GANGLION; BLOOD OXYGENATION; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; FUSIFORM GYRUS; HUMAN; IMAGE ANALYSIS; INSULA; MALE; MENTAL TASK; NEUROIMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; RESPONSE TIME; SCHIZOPHRENIA; TASK PERFORMANCE; THALAMUS;

ADULT; ANALYSIS OF VARIANCE; ARTERIES; BRAIN MAPPING; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; EMOTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; REST; SCHIZOPHRENIA; SPIN LABELS;

EID: 84865329001     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.06.028     Document Type: Article

References (54)

1. Akgoren N., Fabricius M., Lauritzen M. Importance of nitric oxide for local increases of blood flow in rat cerebellar cortex during electrical stimulation. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(13):5903-5907.
2. Alelu-Paz R., Gimenez-Amaya J.M. The mediodorsal thalamic nucleus and schizophrenia. J. Psychiatry Neurosci. 2008, 33(6):489-498.
3. Andreasen N.C., Nopoulos P., O'Leary D.S., Miller D.D., Wassink T., Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol. Psychiatry 1999, 46(7):908-920.
4. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010, 67(3):255-262.
5. Arima H., Tzourio C., Butcher K., Anderson C., Bousser M.G., Lees K.R., Reid J.L., Omae T., Woodward M., MacMahon S., Chalmers J. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial. Stroke 2006, 37(6):1497-1502.
6. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25(1):1-27.
7. Berman K.F., Zec R.F., Weinberger D.R. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch. Gen. Psychiatry 1986, 43(2):126-135.
8. Bogerts B. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr. Bull. 1997, 23(3):423-435.
9. Byne W., Hazlett E.A., Buchsbaum M.S., Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathol. 2009, 117(4):347-368.
10. Cauli B., Tong X.K., Rancillac A., Serluca N., Lambolez B., Rossier J., Hamel E. Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. J. Neurosci. 2004, 24(41):8940-8949.
11. Chakravarthy V.S., Joseph D., Bapi R.S. What do the basal ganglia do? A modeling perspective. Biol. Cybern. 2010, 103(3):237-253.
12. Corson P.W., O'Leary D.S., Miller D.D., Andreasen N.C. The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naive and medicated states. Biol. Psychiatry 2002, 52(9):855-862.
13. Crick F. Function of the thalamic reticular complex: the searchlight hypothesis. Proc. Natl. Acad. Sci. U. S. A. 1984, 81(14):4586-4590.
14. Cronenwett W.J., Csernansky J. Thalamic pathology in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:509-528.
15. Davidson L.L., Heinrichs R.W. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res. 2003, 122(2):69-87.
16. Ferrarelli F., Tononi G. The thalamic reticular nucleus and schizophrenia. Schizophr. Bull. 2011, 37(2):306-315.
17. Filosa J.A., Blanco V.M. Neurovascular coupling in the mammalian brain. Exp. Physiol. 2007, 92(4):641-646.
18. Golay X., Petersen E.T. Arterial spin labeling: benefits and pitfalls of high magnetic field. Neuroimaging Clin. N. Am. 2006, 16(2):259-268.
19. Gur R.E., McGrath C., Chan R.M., Schroeder L., Turner T., Turetsky B.I., Kohler C., Alsop D., Maldjian J., Ragland J.D., Gur R.C. An fMRI study of facial emotion processing in patients with schizophrenia. Am. J. Psychiatry 2002, 159(12):1992-1999.
20. Habel U., Chechko N., Pauly K., Koch K., Backes V., Seiferth N., Shah N.J., Stocker T., Schneider F., Kellermann T. Neural correlates of emotion recognition in schizophrenia. Schizophr. Res. 2010, 122(1-3):113-123.
21. Hill K., Mann L., Laws K.R., Stephenson C.M., Nimmo-Smith I., McKenna P.J. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand. 2004, 110(4):243-256.
22. Horn H., Federspiel A., Wirth M., Muller T.J., Wiest R., Wang J.J., Strik W. Structural and metabolic changes in language areas linked to formal thought disorder. Br. J. Psychiatry 2009, 194(2):130-138.
23. Hoshi Y., Shinba T., Sato C., Doi N. Resting hypofrontality in schizophrenia: a study using near-infrared time-resolved spectroscopy. Schizophr. Res. 2006, 84(2-3):411-420.
24. Ingvar D.H., Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr. Scand. 1974, 50(4):425-462.
25. Izuma K., Saito D.N., Sadato N. Processing of social and monetary rewards in the human striatum. Neuron 2008, 58(2):284-294.
26. Kanahara N., Shimizu E., Sekine Y., Uchida Y., Shibuya T., Yamanaka H., Hashimoto T., Asaka T., Sasaki T., Miyatake R., Ohkami T., Fukami G., Fujisaki M., Watanabe H., Shirayama Y., Hayashi H., Hashimoto K., Asano M., Iyo M. Does hypofrontality expand to global brain area in progression of schizophrenia?: a cross-sectional study between first-episode and chronic schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(3):410-415.
27. Kantrowitz J., Javitt D.C. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr. Opin. Psychiatry 2012, 25(2):96-102.
28. Kocharyan A., Fernandes P., Tong X.K., Vaucher E., Hamel E. Specific subtypes of cortical GABA interneurons contribute to the neurovascular coupling response to basal forebrain stimulation. J. Cereb. Blood Flow Metab. 2008, 28(2):221-231.
29. Lahti A.C., Holcomb H.H., Weiler M.A., Medoff D.R., Tamminga C.A. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol. Psychiatry 2003, 53(7):601-608.
30. Li H., Chan R.C., McAlonan G.M., Gong Q.Y. Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophr. Bull. 2010, 36(5):1029-1039.
31. Li H.J., Chan R.C., Gong Q.Y., Liu Y., Liu S.M., Shum D., Ma Z.L. Facial emotion processing in patients with schizophrenia and their non-psychotic siblings: a functional magnetic resonance imaging study. Schizophr. Res. 2012, 134(2-3):143-150.
32. Lieberman M.D. Social cognitive neuroscience: a review of core processes. Annu. Rev. Psychol. 2007, 58:259-289.
33. Miller D.D., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol. Psychiatry 2001, 49(8):704-715.
34. Perez-Costas E., Melendez-Ferro M., Roberts R.C. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J. Neurochem. 2010, 113(2):287-302.
35. Pinault D. Dysfunctional thalamus-related networks in schizophrenia. Schizophr. Bull. 2011, 37(2):238-243.
36. Qiu M., Ramani R., Swetye M., Rajeevan N., Constable R.T. Anesthetic effects on regional CBF, BOLD, and the coupling between task-induced changes in CBF and BOLD: an fMRI study in normal human subjects. Magn. Reson. Med. 2008, 60(4):987-996.
37. Qiu M., Paul Maguire R., Arora J., Planeta-Wilson B., Weinzimmer D., Wang J., Wang Y., Kim H., Rajeevan N., Huang Y., Carson R.E., Constable R.T. Arterial transit time effects in pulsed arterial spin labeling CBF mapping: insight from a PET and MR study in normal human subjects. Magn. Reson. Med. 2010, 63(2):374-384.
38. Quintana J., Lee J., Marcus M., Kee K., Wong T., Yerevanian A. Brain dysfunctions during facial discrimination in schizophrenia: selective association to affect decoding. Psychiatry Res. 2011, 191(1):44-50.
39. R Development Core Team R: A Language and Environment for Statistical Computing 2011, R Foundation for Statistical Computing Vienna, Austria.
40. Scheef L., Manka C., Daamen M., Kuhn K.U., Maier W., Schild H.H., Jessen F. Resting-state perfusion in nonmedicated schizophrenic patients: a continuous arterial spin-labeling 3.0-T MR study. Radiology 2010, 256(1):253-260.
41. Schmidt M.J., Mirnics K. Modeling interneuron dysfunction in schizophrenia. Dev. Neurosci. 2012, http://dx.doi.org/10.1159/000336731, and link to paper is: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000336731&ProduktNr=224107&filename=000336731.pdf.http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000336731&ProduktNr=224107&filename=000336731.pdf
42. Seiferth N.Y., Pauly K., Kellermann T., Shah N.J., Ott G., Herpertz-Dahlmann B., Kircher T., Schneider F., Habel U. Neuronal correlates of facial emotion discrimination in early onset schizophrenia. Neuropsychopharmacology 2009, 34(2):477-487.
43. Shen L.H., Liao M.H., Tseng Y.C. Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J. Biomed. Biotechnol. 2012, 2012:1-14.
44. Singer T., Kiebel S.J., Winston J.S., Dolan R.J., Frith C.D. Brain responses to the acquired moral status of faces. Neuron 2004, 41(4):653-662.
45. Sprengelmeyer R., Rausch M., Eysel U.T., Przuntek H. Neural structures associated with recognition of facial expressions of basic emotions. Proc. Biol. Sci. 1998, 265(1409):1927-1931.
46. Straub S.V., Nelson M.T. Astrocytic calcium signaling: the information currency coupling neuronal activity to the cerebral microcirculation. Trends Cardiovasc. Med. 2007, 17(6):183-190.
47. Surguladze S.A., Chu E.M., Marshall N., Evans A., Anilkumar A.P., Timehin C., McDonald C., Ecker C., Phillips M.L., David A.S. Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication. J. Psychopharmacol. 2011, 25(6):722-733.
48. Tomelleri L., Jogia J., Perlini C., Bellani M., Ferro A., Rambaldelli G., Tansella M., Frangou S., Brambilla P. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia. Eur. Neuropsychopharmacol. 2009, 19(12):835-840.
49. Uranova N.A., Zimina I.S., Vikhreva O.V., Krukov N.O., Rachmanova V.I., Orlovskaya D.D. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J. Biol. Psychiatry 2010, 11(3):567-578.
50. Vita A., De Peri L. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int. Rev. Psychiatry 2007, 19(4):429-436.
51. Weinberger D.R., Berman K.F. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr. Bull. 1988, 14(2):157-168.
52. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 1986, 43(2):114-124.
53. Wexler B.E., Halwes T. Increasing the power of dichotic methods: the fused rhymed words test. Neuropsychologia 1983, 21(1):59-66.
54. Yamauchi H., Okazawa H., Kishibe Y., Sugimoto K., Takahashi M. The effect of acetazolamide on the changes of cerebral blood flow and oxygen metabolism during visual stimulation. Neuroimage 2003, 20(1):543-549.